Cargando…
Establishing and Sustaining a Prospective Screening Program for Breast Cancer-Related Lymphedema at the Massachusetts General Hospital: Lessons Learned
There has been an increasing call to prospectively screen patients with breast cancer for the development of breast cancer-related lymphedema (BCRL) following their breast cancer treatment. While the components of a prospective screening program have been published, some centers struggle with how to...
Autores principales: | Brunelle, Cheryl, Skolny, Melissa, Ferguson, Chantal, Swaroop, Meyha, O’Toole, Jean, Taghian, Alphonse G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493493/ https://www.ncbi.nlm.nih.gov/pubmed/26011383 http://dx.doi.org/10.3390/jpm5020153 |
Ejemplares similares
-
Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort
por: Swaroop, Meyha N., et al.
Publicado: (2015) -
A retrospective analysis of commonly prescribed medications and the risk of developing breast cancer related lymphedema
por: Meijer, Eelco FJ, et al.
Publicado: (2020) -
Lymphoedema screening: setting the standard
por: Brunelle, Cheryl L., et al.
Publicado: (2020) -
Massachusetts' General Hospital
Publicado: (1830) -
Massachusetts General Hospital
Publicado: (1850)